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Abstract
Background: Esophageal perforation is a rare presenting sign of gastric cancer. To date, only nine case reports of
this phenomenon have been previously published.
Case presentation: Esophageal perforation was diagnosed radiographically during workup for acute chest pain in
a 67-year-old man. Emergent endoscopy confirmed esophageal perforation and biopsied a pre-pyloric mass
confirmed to be adenocarcinoma. The perforation was managed with endoscopically placed transluminal pleural
and mediastinal drains and esophageal stenting. The gastric outlet obstruction was temporized with a transpyloric
stent. After the patient recovered from sepsis, distal gastrectomy was performed and he made a full recovery.
Conclusions: Rarely, pre-pyloric gastric cancer can present with Boerhaave syndrome, spontaneous esophageal
perforation associated with forceful vomiting. We present the tenth report in the literature of this phenomenon
and the first to be initially treated with endoscopic stenting and transluminal thoracoscopic drainage. When
endoscopic management is used to treat patients with Boerhaave syndrome, it may be beneficial to examine
the entire stomach to evaluate for malignant etiology.
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Background
Gastric cancer is a major source of global burden of dis-
ease and mortality. Though it is the fifth most common
malignancy worldwide, it is the third leading cause of
cancer deaths [1]. The majority of cases are either locally
advanced or metastatic at the time of diagnosis, with
5-year survival rates of 20–60% depending on the coun-
try [2]. Many patients are asymptomatic from the pri-
mary tumor or report nonspecific symptoms such as
weight loss, abdominal pain, nausea, anorexia, and/or
dysphagia [3]. Rarely, distal gastric cancer presents dra-
matically with esophageal perforation as the first sign of
disease. To date, nine case reports of this unusual pres-
entation have been published. Herein, we present the
tenth reported case of esophageal perforation secondary
to malignant gastric outlet obstruction and the first to
be initially treated by endoscopic stenting and translumi-
nal thoracoscopic drainage of the perforation and endo-
scopic stenting of the gastric outflow obstruction.
Case presentation
A 67-year-old man presented to the emergency room for
acute chest pain, dyspnea, and chills. On further ques-
tioning, he reported 1 month of nausea, vomiting, and
dysphagia and an unintentional 90-lb weight loss over
the past year. Social history was notable for tobacco
abuse of one pack per day and occasional alcohol use.
Family history was significant for unspecified malignancy
in both parents and a daughter, as well as gastric cancer
in a brother and granddaughter. On exam, he was tachy-
cardic (heart rate 110 beats/min), hypotensive (blood
pressure 86/68 mmHg), and tachypneic (respiratory rate
40 breaths/min) and had diffuse left costal chest tender-
ness. Given his history of hypertension, cardiac workup
was performed and was negative. Computed tomography
(CT) of the chest was obtained and revealed an
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esophageal perforation and thickening of the gastric pyl-
orus (Fig. 1), for which Thoracic Surgery was consulted.
A left pleural 14-French (Fr) pigtail catheter was placed
at the bedside to alleviate a large hydropneumothorax
with tension component, and the patient was taken to
the operating room emergently for endoscopic evalu-
ation, wide drainage, and possible stenting.
Esophagogastroduodenoscopy with fluoroscopy (Video 1
https://figshare.com/s/cbaef7705075bcb7a58f) showed a
large perforation of the distal esophagus just proximal to
the gastro-esophageal (GE) junction, a large fluid- and
food-filled stomach, and a large ulcerative pre-pyloric mass
(Fig. 2) which was biopsied. The esophageal perforation
comprised approximately 30% of the circumference, was
over 4 cm in length, and freely communicated with the pos-
terior mediastinum and left pleural cavity (Fig. 3a). The
endoscope was navigated across the perforation and passed
alongside the pigtail catheter, using it to exteriorize the
guidewire and endoscopic graspers. No 10 Jackson Pratt
and 24-Fr Blake drains were then guided endoscopically across the chest wall into posterior mediastinum and
sub-pulmonic pleural cavity directly adjacent to the luminal
perforation to ensure wide, direct drainage. Bilateral per-
cutaneous postero-apical pleural drainage tubes were
then placed. The esophageal perforation was covered
with a 23 × 120mm fully covered stent (Alimaxx-ES,
Merit Medical Systems, Utah). A nasogastric tube and
20-Fr percutaneous gastrostomy tube were placed to fa-
cilitate decompression in the setting of gastric outlet ob-
struction. Postoperatively, the patient was transferred to
the intensive care unit where he was treated for septic
shock with intravenous antimicrobial therapy and sup-
portive care.
The biopsy pathology and touch preparation cytology
were discordant, so the patient was taken back to the
operating room for repeat endoscopic biopsies when he
was clinically stable. At this time, a temporary 23 × 100
mm covered stent was placed in a transpyloric position
to alleviate the gastric outlet obstruction. Final pathology
confirmed adenocarcinoma (Fig. 4).
Approximately 2 weeks later, the pyloric stent had
started to migrate distally. In the absence of clinical
and radiologic evidence of metastatic disease, surgi-
cal staging with possible concurrent oncologic resec-
tion was discussed with the patient and family, who
elected to proceed. A distal gastrectomy with Bill-
roth II reconstruction was performed, along with the
removal of the temporizing transpyloric stent. Given
the urgent nature of the procedure in a chronically
ill patient still recovering from sepsis, extensive
lymphadenectomy was not performed. Final path-
ology was pT2 pN1 (AJCC eighth edition), with a
1.8-cm moderately differentiated gastric adenocarcin-
oma with negative margins, and two of two lymph
Fig. 1 CT of the chest, abdomen, and pelvis with intravenous contrast.
a Pneumomediastinum, left hydropneumothorax with rightward
mediastinal shift, and right pleural effusion. b The distended,
fluid-filled stomach with thickening of the pylorus consistent
with gastric outlet obstruction
Fig. 2 Pre-pyloric mass visualized on initial endoscopy
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nodes evidencing metastatic disease including focal
extra-nodal extension.
The patient required hospitalization for nearly
3 months for infection control, nutritional support, and
physical rehabilitation. Four serial endoscopies were per-
formed during this time for esophageal evaluation
(Fig. 3b, c) and transluminal drain adjustments. The
esophageal stent was noted to be in an appropriate pos-
ition and was removed prior to discharge to a skilled
nursing facility. After his functional status improved, the
patient was referred to the Medical Oncology and Radiation
Oncology for evaluation for adjuvant therapy for locally ad-
vanced disease. He is currently tolerating a regular diet and
is fully ambulatory without support.
Discussion and conclusions
This is the tenth reported case of esophageal perforation
secondary to gastric outlet obstruction (GOO) from gas-
tric cancer and the first to be temporized by esophageal
and pyloric stenting with transluminal perforation
management. Previously, Matsuhashi and colleagues [4]
published the first English language case report of
esophageal perforation secondary to malignant GOO.
Their 2011 literature review identified five other similar
cases. Our search yielded three additional cases [5–7].
Nine of the ten cases occurred in males, and the mean
age was 63.2 years (range 47–73). All patients were
treated with either distal or total gastrectomy, either
concurrently with emergent surgical management of the
esophageal perforation or after recovery from sepsis.
The majority of patients were alive at the time of publi-
cation of their case report; however, follow-up times
were quite variable (5 months to 6 years).
Significantly, the location of the tumor in all ten cases
was pre-pyloric. The pathophysiology of the spontaneous
esophageal perforations observed in these patients may
be explained by malignant invasion of the pylorus incit-
ing forceful vomiting akin to pyloric stenosis. Further-
more, it is likely that the stomach was unable to diffuse
much of the force of retching as it was already max-
imally distended from months of accumulation of fluid
and particulates secondary to poor gastric outflow.
Boerhaave syndrome, spontaneous esophageal rupture
due to a sudden increase in intra-esophageal pressure
often due to forceful vomiting, is a rare phenomenon
with a mortality rate of about 40% [8]. Treatment
options include surgical repair, operative drainage, endo-
scopic stenting, and non-operative management. Endo-
scopic management is gaining increasing popularity [9].
When this treatment method is chosen, it may be prudent
to perform a complete esophagogastroduodenoscopy. In-
deed, our case highlights the benefit of inspecting the
gastrointestinal mucosa distal to the site of the perforation
to evaluate for a malignant etiology.
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